ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 86371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 86371; 2) Community: the network communities that were significantly associated with the response to NSC 86371; 3) Molecule: the relationships between components within communities and NSC 86371; 4) MDR: the compounds that were significantly associated with the NSC 86371.

NSC Compound Enrichment Correlation
NSC 756413 GW876790X 0.0114553853234977 -0.37980458
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0119653763676521 0.42308003
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.0119653763676521 0.45969843
NSC 665694 2-Propen-1-one, 1-(4-hydroxyphenyl)- 3-[4-(dimethylamino)phenyl]- 0.0119653763676521 0.49644138
NSC 666667 Null 0.0119653763676521 0.46668342
NSC 712735 Null 0.0119653763676521 0.17354525
NSC 8120 Claviform 0.0119653763676521 0.48430223
NSC 674007 4-Chloro-N-(N-(4-chlorophenyl)carbamohydrazonoyl)-2-mercapto-5-methylbenzenesulfonamide 0.0131142867047947 0.21083115
NSC 124764 Methanesulfonic acid, thio-, S-hexadecyl ester (8CI) 0.0131142867047949 0.32702826
NSC 135077 BERSALDEGENIN 1,3,5-ORTHOACETATE 0.0131142867047949 0.2676086
Total:139  Current:52    [First] [Prev] [Next] [Last]